Amoxicillin: Difference between revisions

Jump to navigation Jump to search
m (Changed protection level for "Amoxicillin" ([Edit=Allow only autoconfirmed users] (expires 20:21, 6 January 2014 (UTC)) [Move=Allow only autoconfirmed users] (expires 20:21, 6 January 2014 (UTC))))
Line 6: Line 6:
'''Amoxicillin''' ([[International Nonproprietary Name|INN]]), formerly '''amoxycillin''' ([[British Approved Name|BAN]]), and abbreviated '''amox''', is a moderate-spectrum, bacteriolytic, [[beta-lactam antibiotic|β-lactam]] [[antibiotic]] used to treat [[bacterial]] [[infection]]s caused by susceptible [[microorganism]]s. It is usually the drug of choice within the class because it is better absorbed, following oral administration, than other β-lactam antibiotics. Amoxicillin is one of the most common [[antibiotic]]s prescribed for children.  The drug first became available in [[Timeline of antibiotics|1972]].
'''Amoxicillin''' ([[International Nonproprietary Name|INN]]), formerly '''amoxycillin''' ([[British Approved Name|BAN]]), and abbreviated '''amox''', is a moderate-spectrum, bacteriolytic, [[beta-lactam antibiotic|β-lactam]] [[antibiotic]] used to treat [[bacterial]] [[infection]]s caused by susceptible [[microorganism]]s. It is usually the drug of choice within the class because it is better absorbed, following oral administration, than other β-lactam antibiotics. Amoxicillin is one of the most common [[antibiotic]]s prescribed for children.  The drug first became available in [[Timeline of antibiotics|1972]].


Amoxicillin is susceptible to degradation by [[beta-lactamase|β-lactamase]]-producing bacteria, which are resistant to a broad spectrum of β-lactam antibiotics, such as penicillin.  For this reason, it is often combined with [[clavulanic acid]], a β-lactamase inhibitor. This increases effectiveness by reducing its susceptibility to β-lactamase resistance.<ref>{{cite web|title=Amoxicillin Susceptibility and Resistance Data|url=http://www.toku-e.com/Assets/MIC/AmoxicillinClavulanate%20augmentin.pdf|accessdate=20 July 2013}}</ref>
Amoxicillin is susceptible to degradation by [[beta-lactamase|β-lactamase]]-producing bacteria, which are resistant to a broad spectrum of β-lactam antibiotics, such as penicillin.  For this reason, it is often combined with [[clavulanic acid]], a β-lactamase inhibitor. This increases effectiveness by reducing its susceptibility to β-lactamase resistance.<ref>{{cite web|title=Amoxicillin Susceptibility and Resistance Data|url=http://www.toku-e.com/Assets/MIC/AmoxicillinClavulanate%20augmentin.pdf|accessdate}}</ref>


==Category==
==Category==

Revision as of 02:24, 22 January 2014

Amoxicillin
MOXATAG® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]

Overview

Amoxicillin (INN), formerly amoxycillin (BAN), and abbreviated amox, is a moderate-spectrum, bacteriolytic, β-lactam antibiotic used to treat bacterial infections caused by susceptible microorganisms. It is usually the drug of choice within the class because it is better absorbed, following oral administration, than other β-lactam antibiotics. Amoxicillin is one of the most common antibiotics prescribed for children. The drug first became available in 1972.

Amoxicillin is susceptible to degradation by β-lactamase-producing bacteria, which are resistant to a broad spectrum of β-lactam antibiotics, such as penicillin. For this reason, it is often combined with clavulanic acid, a β-lactamase inhibitor. This increases effectiveness by reducing its susceptibility to β-lactamase resistance.[1]

Category

β-lactam antibiotic

US Brand Names

MOXATAG®

FDA Package Insert

Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Dosage and Administration | How Supplied

Mechanism of Action

Amoxicillin is similar to ampicillin in its bactericidal action against susceptible organisms during the stage of active multiplication. It acts through the inhibition of biosynthesis of cell wall mucopeptide.

References

  1. "Amoxicillin Susceptibility and Resistance Data" (PDF). Text "accessdate" ignored (help)